- Investing.com
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.
Future Prospects | Analyst price targets range from $32 to $35, reflecting optimism about Phreesia's growth potential in the evolving digital health landscape |
Market Expansion | Delve into Phreesia's success in securing large specialty provider networks and its comprehensive approach to digital health solutions |
Financial Trajectory | Explore Phreesia's path to profitability, with improving EBITDA and a strategic focus on becoming a Rule of 30+ profile company |
Digital Health Pionee | Phreesia leads in patient-facing software and pharma advertising, showcasing robust revenue growth and a strong gross margin in the healthcare IT secto |

Metrics to compare | PHR | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipPHRPeersSector | |
|---|---|---|---|---|
P/E Ratio | 238.7x | 11.2x | −0.5x | |
PEG Ratio | 2.28 | 0.04 | 0.00 | |
Price / Book | 1.6x | 1.6x | 2.6x | |
Price / LTM Sales | 1.1x | 1.0x | 3.2x | |
Upside (Analyst Target) | 72.8% | 58.0% | 45.7% | |
Fair Value Upside | Unlock | 29.6% | 4.8% | Unlock |